{"gene":"ARR3","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2016,"finding":"Heterozygous loss-of-function mutations in ARR3 (encoding cone arrestin) cause X-linked female-limited early-onset high myopia; missense and truncating variants in ARR3 co-segregate with disease exclusively in heterozygous females, while hemizygous males are unaffected, establishing an unusual X-linked female-limited inheritance pattern.","method":"Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, co-segregation analysis in three families","journal":"Molecular vision","confidence":"High","confidence_rationale":"Tier 2 — replicated across multiple families and independently confirmed in subsequent studies","pmids":["27829781"],"is_preprint":false},{"year":2021,"finding":"A nonsense mutation in ARR3 (c.569C>G, p.S190*) causes nonsense-mediated decay of ARR3 mutant mRNA, establishing that loss of ARR3 protein via NMD is a pathogenic mechanism for high myopia.","method":"Exome sequencing, functional characterization of nonsense-mediated mRNA decay of mutant ARR3 transcript","journal":"Frontiers in genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct molecular assay of NMD, single lab","pmids":["34966409"],"is_preprint":false},{"year":2023,"finding":"X-chromosome inactivation (XCI) in heterozygous females creates a mosaic retina where some cones express mutant ARR3 and others express wild-type ARR3, providing a mechanistic explanation for why heterozygous females (but not hemizygous males) develop myopia.","method":"X-chromosome inactivation experiments in a family with frameshift ARR3 variant; correlation of skewed XCI with phenotypic severity","journal":"Journal of clinical medicine","confidence":"Medium","confidence_rationale":"Tier 2 — direct XCI assay with phenotypic correlation, single lab","pmids":["36769483"],"is_preprint":false},{"year":2024,"finding":"Two novel ARR3 splicing variants (c.39+1G>A and c.100+4A>G) cause abnormal splicing and introduction of premature termination codons, confirming that disruption of ARR3 mRNA splicing is a pathogenic mechanism for early-onset high myopia.","method":"Minigene splicing assay demonstrating aberrant splicing and premature stop codons from ARR3 variants","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 — direct functional minigene assay with molecular readout","pmids":["38517428"],"is_preprint":false},{"year":2024,"finding":"Cone dysfunction (reduced light-adapted ERG a- and b-wave amplitudes by ~35%, and flicker ERG by ~55%) in Myopia-26 patients is specifically linked to ARR3 mutation and is not a secondary consequence of axial elongation, establishing that ARR3 is required for normal cone photoreceptor function.","method":"Full-field electroretinography (ERG) in genetically characterized ARR3-mutation carriers versus high myopes with intact ARR3 alleles","journal":"Orphanet journal of rare diseases","confidence":"Medium","confidence_rationale":"Tier 2 — controlled electrophysiological study with genetic stratification, single lab","pmids":["39420435"],"is_preprint":false},{"year":2026,"finding":"ARR3 (cone arrestin) is localized to outer segments of red/green opsin-positive cone photoreceptors in the mouse retina from postnatal day 14 onward. Heterozygous Arr3 deficiency in knock-in mice and knockout rats creates a mosaic pattern of Arr3 expression, shifts cone subtype proportions (reducing M/S cones, increasing S cones), and alters expression of Pde6h specifically in M/S cones, suggesting that cone mosaicism disrupts phototransduction signaling and may mimic retinal defocus-like signals driving myopia development.","method":"Developmental expression profiling, immunolocalization, retinal flatmounts from Arr3 knock-in mice and knockout rats, single-cell RNA sequencing of retina","journal":"Zoological research","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (localization, scRNA-seq, animal models) in a single study","pmids":["41493082"],"is_preprint":false}],"current_model":"ARR3 encodes cone arrestin, expressed in outer segments of red/green cone photoreceptors from early postnatal development; it is required for normal cone phototransduction (inactivating phosphorylated opsins), and heterozygous loss-of-function variants cause a mosaic retinal state via X-chromosome inactivation—where cones expressing mutant ARR3 coexist with wild-type cones—disrupting cone subtype composition and phototransduction (including Pde6h expression), and generating defocus-like signals that drive early-onset high myopia specifically in heterozygous females."},"narrative":{"teleology":[{"year":2016,"claim":"The genetic basis of an unusual female-limited high myopia was unknown; linkage and exome sequencing in three families demonstrated that heterozygous loss-of-function ARR3 variants co-segregate with early-onset high myopia exclusively in females, establishing ARR3 as a disease gene with X-linked female-limited inheritance.","evidence":"Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, and co-segregation analysis across three independent families","pmids":["27829781"],"confidence":"High","gaps":["Mechanism by which ARR3 loss leads to myopia rather than retinal degeneration was unknown","Why hemizygous males are unaffected was unexplained","No functional assay of variant pathogenicity was performed"]},{"year":2021,"claim":"It was unclear whether ARR3 missense/truncating variants actually eliminate protein; demonstration that a nonsense ARR3 variant triggers nonsense-mediated mRNA decay established that complete loss of ARR3 protein is the pathogenic mechanism.","evidence":"Exome sequencing and functional NMD assay of c.569C>G (p.S190*) transcript in patient cells","pmids":["34966409"],"confidence":"Medium","gaps":["NMD demonstrated for a single variant; generalizability to other mutation classes not yet shown","No animal model to confirm loss-of-function consequences on cone physiology"]},{"year":2023,"claim":"The paradox of female-limited disease from an X-linked gene was resolved when X-chromosome inactivation assays showed that heterozygous females have mosaic retinas with patches of mutant and wild-type ARR3-expressing cones, and skewed XCI correlated with phenotypic severity.","evidence":"X-chromosome inactivation analysis and phenotypic correlation in a family carrying a frameshift ARR3 variant","pmids":["36769483"],"confidence":"Medium","gaps":["Mosaic retinal pattern not directly visualized at cellular resolution in human tissue","Mechanism linking mosaicism to myopia signaling remained speculative"]},{"year":2024,"claim":"Expanding the mutational spectrum, minigene assays demonstrated that ARR3 splicing variants introduce premature termination codons, confirming that disruption of mRNA processing is another pathogenic mechanism and broadening the class of disease-causing alleles.","evidence":"Minigene splicing assay for two novel ARR3 intronic variants (c.39+1G>A and c.100+4A>G)","pmids":["38517428"],"confidence":"High","gaps":["Endogenous splicing consequences in cone photoreceptors not verified","Quantitative effect on ARR3 protein levels not measured"]},{"year":2024,"claim":"Whether ARR3 mutations impair cone function directly—or myopia-associated elongation secondarily degrades cones—was resolved by ERG studies showing cone dysfunction (35% reduced a/b-wave, 55% reduced flicker) specific to ARR3 carriers versus myopes with intact ARR3, establishing a primary cone signaling deficit.","evidence":"Full-field electroretinography in genetically stratified ARR3-mutation carriers versus ARR3-intact high myopes","pmids":["39420435"],"confidence":"Medium","gaps":["Single-center study; independent replication in larger cohorts needed","Which step in cone phototransduction is specifically disrupted remains unresolved"]},{"year":2026,"claim":"The cellular and molecular consequences of mosaic ARR3 loss were defined: ARR3 localizes to outer segments of M-cones from P14, and heterozygous loss in mice/rats shifts cone subtype proportions and alters Pde6h expression in M/S cones, suggesting that mosaicism disrupts phototransduction and generates defocus-like signals driving myopia.","evidence":"Developmental expression profiling, immunolocalization, retinal flatmounts in Arr3 knock-in mice and knockout rats, single-cell RNA sequencing","pmids":["41493082"],"confidence":"High","gaps":["Causal link between cone mosaicism and axial elongation signaling not directly demonstrated","Downstream retinal signaling pathway translating phototransduction disruption into scleral growth not identified","Whether S-cone enrichment itself contributes to myopia signals is untested"]},{"year":null,"claim":"The mechanism by which mosaic cone phototransduction disruption is transduced into scleral remodeling and axial elongation—the ultimate cause of myopia—remains unknown.","evidence":"","pmids":[],"confidence":"Low","gaps":["No identification of retina-to-sclera signaling intermediates downstream of ARR3-dependent cone mosaicism","No structural model of ARR3 interaction with cone opsins","No therapeutic rescue experiments in animal models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5]}],"pathway":[],"complexes":[],"partners":["PDE6H"],"other_free_text":[]},"mechanistic_narrative":"ARR3 encodes cone arrestin, a visual arrestin expressed in the outer segments of red/green cone photoreceptors that is required for normal cone phototransduction [PMID:41493082, PMID:39420435]. Loss-of-function mutations—including nonsense, splicing, and frameshift variants—cause premature termination and nonsense-mediated mRNA decay, abolishing ARR3 protein production [PMID:34966409, PMID:38517428]. Heterozygous loss-of-function variants in ARR3 cause X-linked female-limited early-onset high myopia (Myopia-26) through an X-chromosome inactivation mechanism that generates a mosaic retina in which ARR3-null and ARR3-expressing cones coexist, disrupting cone subtype composition, Pde6h expression, and phototransduction signaling [PMID:27829781, PMID:36769483, PMID:41493082]. ARR3 mutation carriers exhibit cone-specific electrophysiological dysfunction independent of axial elongation, confirming a primary role in cone photoreceptor signaling [PMID:39420435]."},"prefetch_data":{"uniprot":{"accession":"P36575","full_name":"Arrestin-C","aliases":["Cone arrestin","C-arrestin","cArr","Retinal cone arrestin-3","X-arrestin"],"length_aa":388,"mass_kda":42.8,"function":"May play a role in an as yet undefined retina-specific signal transduction. Could bind to photoactivated-phosphorylated red/green opsins","subcellular_location":"Photoreceptor inner segment; Cell projection, cilium, photoreceptor outer segment","url":"https://www.uniprot.org/uniprotkb/P36575/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARR3","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ARR3","total_profiled":1310},"omim":[{"mim_id":"614423","title":"TRANSMEMBRANE PROTEIN 237; TMEM237","url":"https://www.omim.org/entry/614423"},{"mim_id":"613598","title":"ZINC FINGER PROTEIN 513; ZNF513","url":"https://www.omim.org/entry/613598"},{"mim_id":"301770","title":"ARRESTIN 3, RETINAL; ARR3","url":"https://www.omim.org/entry/301770"},{"mim_id":"301010","title":"MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26","url":"https://www.omim.org/entry/301010"},{"mim_id":"160700","title":"MYOPIA 2, AUTOSOMAL DOMINANT; MYP2","url":"https://www.omim.org/entry/160700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":357.5}],"url":"https://www.proteinatlas.org/search/ARR3"},"hgnc":{"alias_symbol":["ARRX"],"prev_symbol":[]},"alphafold":{"accession":"P36575","domains":[{"cath_id":"2.60.40.840","chopping":"3-172_363-368","consensus_level":"medium","plddt":89.5211,"start":3,"end":368},{"cath_id":"2.60.40.640","chopping":"181-350","consensus_level":"medium","plddt":89.2972,"start":181,"end":350}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P36575","model_url":"https://alphafold.ebi.ac.uk/files/AF-P36575-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P36575-F1-predicted_aligned_error_v6.png","plddt_mean":86.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARR3","jax_strain_url":"https://www.jax.org/strain/search?query=ARR3"},"sequence":{"accession":"P36575","fasta_url":"https://rest.uniprot.org/uniprotkb/P36575.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P36575/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P36575"}},"corpus_meta":[{"pmid":"27829781","id":"PMC_27829781","title":"X-linked heterozygous mutations in ARR3 cause female-limited early onset high myopia.","date":"2016","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/27829781","citation_count":62,"is_preprint":false},{"pmid":"36180177","id":"PMC_36180177","title":"Genetic and clinical landscape of ARR3-associated MYP26: the most common cause of Mendelian early-onset high myopia with a unique inheritance.","date":"2022","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/36180177","citation_count":30,"is_preprint":false},{"pmid":"35001458","id":"PMC_35001458","title":"Early onset X-linked female limited high myopia in three multigenerational families caused by novel mutations in the ARR3 gene.","date":"2022","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/35001458","citation_count":24,"is_preprint":false},{"pmid":"37268727","id":"PMC_37268727","title":"The causal mutation in ARR3 gene for high myopia and progressive color vision defect.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37268727","citation_count":15,"is_preprint":false},{"pmid":"34966409","id":"PMC_34966409","title":"Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34966409","citation_count":13,"is_preprint":false},{"pmid":"36769483","id":"PMC_36769483","title":"Identification of a Novel Frameshift Variant of ARR3 Related to X-Linked Female-Limited Early-Onset High Myopia and Study on the Effect of X Chromosome Inactivation on the Myopia Severity.","date":"2023","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36769483","citation_count":8,"is_preprint":false},{"pmid":"18509847","id":"PMC_18509847","title":"Common industrial sake yeast strains have three copies of the AQY1-ARR3 region of chromosome XVI in their genomes.","date":"2008","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18509847","citation_count":7,"is_preprint":false},{"pmid":"39420435","id":"PMC_39420435","title":"Cone dysfunction in ARR3-mutation-associated early-onset high myopia: an electrophysiological study.","date":"2024","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/39420435","citation_count":4,"is_preprint":false},{"pmid":"40134578","id":"PMC_40134578","title":"Advances in the study of ARR3 in myopia.","date":"2025","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/40134578","citation_count":3,"is_preprint":false},{"pmid":"33538578","id":"PMC_33538578","title":"Structural and Functional Investigation of the Periplasmic Arsenate-Binding Protein ArrX from Chrysiogenes arsenatis.","date":"2021","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33538578","citation_count":3,"is_preprint":false},{"pmid":"38517428","id":"PMC_38517428","title":"Novel Splicing Variants in the ARR3 Gene Cause the Female-Limited Early-Onset High Myopia.","date":"2024","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/38517428","citation_count":3,"is_preprint":false},{"pmid":"39775075","id":"PMC_39775075","title":"Dissemination of arr-2 and arr-3 is associated with class 1 integrons in Klebsiella pneumoniae clinical isolates from Portugal.","date":"2025","source":"Medical microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39775075","citation_count":1,"is_preprint":false},{"pmid":"41493082","id":"PMC_41493082","title":"ARR3 variant-induced cone mosaicism alters cone subtype composition and disrupts phototransduction.","date":"2026","source":"Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/41493082","citation_count":0,"is_preprint":false},{"pmid":"41076047","id":"PMC_41076047","title":"The association of ARR3 genetic polymorphisms with pathologic myopia in Northern Chinese population.","date":"2025","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/41076047","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8001,"output_tokens":1445,"usd":0.022839},"stage2":{"model":"claude-opus-4-6","input_tokens":4685,"output_tokens":3773,"usd":0.176625},"total_usd":0.199464,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"Heterozygous loss-of-function mutations in ARR3 (encoding cone arrestin) cause X-linked female-limited early-onset high myopia; missense and truncating variants in ARR3 co-segregate with disease exclusively in heterozygous females, while hemizygous males are unaffected, establishing an unusual X-linked female-limited inheritance pattern.\",\n      \"method\": \"Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, co-segregation analysis in three families\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across multiple families and independently confirmed in subsequent studies\",\n      \"pmids\": [\"27829781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"A nonsense mutation in ARR3 (c.569C>G, p.S190*) causes nonsense-mediated decay of ARR3 mutant mRNA, establishing that loss of ARR3 protein via NMD is a pathogenic mechanism for high myopia.\",\n      \"method\": \"Exome sequencing, functional characterization of nonsense-mediated mRNA decay of mutant ARR3 transcript\",\n      \"journal\": \"Frontiers in genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct molecular assay of NMD, single lab\",\n      \"pmids\": [\"34966409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"X-chromosome inactivation (XCI) in heterozygous females creates a mosaic retina where some cones express mutant ARR3 and others express wild-type ARR3, providing a mechanistic explanation for why heterozygous females (but not hemizygous males) develop myopia.\",\n      \"method\": \"X-chromosome inactivation experiments in a family with frameshift ARR3 variant; correlation of skewed XCI with phenotypic severity\",\n      \"journal\": \"Journal of clinical medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct XCI assay with phenotypic correlation, single lab\",\n      \"pmids\": [\"36769483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Two novel ARR3 splicing variants (c.39+1G>A and c.100+4A>G) cause abnormal splicing and introduction of premature termination codons, confirming that disruption of ARR3 mRNA splicing is a pathogenic mechanism for early-onset high myopia.\",\n      \"method\": \"Minigene splicing assay demonstrating aberrant splicing and premature stop codons from ARR3 variants\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional minigene assay with molecular readout\",\n      \"pmids\": [\"38517428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cone dysfunction (reduced light-adapted ERG a- and b-wave amplitudes by ~35%, and flicker ERG by ~55%) in Myopia-26 patients is specifically linked to ARR3 mutation and is not a secondary consequence of axial elongation, establishing that ARR3 is required for normal cone photoreceptor function.\",\n      \"method\": \"Full-field electroretinography (ERG) in genetically characterized ARR3-mutation carriers versus high myopes with intact ARR3 alleles\",\n      \"journal\": \"Orphanet journal of rare diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — controlled electrophysiological study with genetic stratification, single lab\",\n      \"pmids\": [\"39420435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"ARR3 (cone arrestin) is localized to outer segments of red/green opsin-positive cone photoreceptors in the mouse retina from postnatal day 14 onward. Heterozygous Arr3 deficiency in knock-in mice and knockout rats creates a mosaic pattern of Arr3 expression, shifts cone subtype proportions (reducing M/S cones, increasing S cones), and alters expression of Pde6h specifically in M/S cones, suggesting that cone mosaicism disrupts phototransduction signaling and may mimic retinal defocus-like signals driving myopia development.\",\n      \"method\": \"Developmental expression profiling, immunolocalization, retinal flatmounts from Arr3 knock-in mice and knockout rats, single-cell RNA sequencing of retina\",\n      \"journal\": \"Zoological research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (localization, scRNA-seq, animal models) in a single study\",\n      \"pmids\": [\"41493082\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARR3 encodes cone arrestin, expressed in outer segments of red/green cone photoreceptors from early postnatal development; it is required for normal cone phototransduction (inactivating phosphorylated opsins), and heterozygous loss-of-function variants cause a mosaic retinal state via X-chromosome inactivation—where cones expressing mutant ARR3 coexist with wild-type cones—disrupting cone subtype composition and phototransduction (including Pde6h expression), and generating defocus-like signals that drive early-onset high myopia specifically in heterozygous females.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARR3 encodes cone arrestin, a visual arrestin expressed in the outer segments of red/green cone photoreceptors that is required for normal cone phototransduction [PMID:41493082, PMID:39420435]. Loss-of-function mutations—including nonsense, splicing, and frameshift variants—cause premature termination and nonsense-mediated mRNA decay, abolishing ARR3 protein production [PMID:34966409, PMID:38517428]. Heterozygous loss-of-function variants in ARR3 cause X-linked female-limited early-onset high myopia (Myopia-26) through an X-chromosome inactivation mechanism that generates a mosaic retina in which ARR3-null and ARR3-expressing cones coexist, disrupting cone subtype composition, Pde6h expression, and phototransduction signaling [PMID:27829781, PMID:36769483, PMID:41493082]. ARR3 mutation carriers exhibit cone-specific electrophysiological dysfunction independent of axial elongation, confirming a primary role in cone photoreceptor signaling [PMID:39420435].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"The genetic basis of an unusual female-limited high myopia was unknown; linkage and exome sequencing in three families demonstrated that heterozygous loss-of-function ARR3 variants co-segregate with early-onset high myopia exclusively in females, establishing ARR3 as a disease gene with X-linked female-limited inheritance.\",\n      \"evidence\": \"Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, and co-segregation analysis across three independent families\",\n      \"pmids\": [\"27829781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which ARR3 loss leads to myopia rather than retinal degeneration was unknown\",\n        \"Why hemizygous males are unaffected was unexplained\",\n        \"No functional assay of variant pathogenicity was performed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"It was unclear whether ARR3 missense/truncating variants actually eliminate protein; demonstration that a nonsense ARR3 variant triggers nonsense-mediated mRNA decay established that complete loss of ARR3 protein is the pathogenic mechanism.\",\n      \"evidence\": \"Exome sequencing and functional NMD assay of c.569C>G (p.S190*) transcript in patient cells\",\n      \"pmids\": [\"34966409\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"NMD demonstrated for a single variant; generalizability to other mutation classes not yet shown\",\n        \"No animal model to confirm loss-of-function consequences on cone physiology\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The paradox of female-limited disease from an X-linked gene was resolved when X-chromosome inactivation assays showed that heterozygous females have mosaic retinas with patches of mutant and wild-type ARR3-expressing cones, and skewed XCI correlated with phenotypic severity.\",\n      \"evidence\": \"X-chromosome inactivation analysis and phenotypic correlation in a family carrying a frameshift ARR3 variant\",\n      \"pmids\": [\"36769483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mosaic retinal pattern not directly visualized at cellular resolution in human tissue\",\n        \"Mechanism linking mosaicism to myopia signaling remained speculative\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanding the mutational spectrum, minigene assays demonstrated that ARR3 splicing variants introduce premature termination codons, confirming that disruption of mRNA processing is another pathogenic mechanism and broadening the class of disease-causing alleles.\",\n      \"evidence\": \"Minigene splicing assay for two novel ARR3 intronic variants (c.39+1G>A and c.100+4A>G)\",\n      \"pmids\": [\"38517428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Endogenous splicing consequences in cone photoreceptors not verified\",\n        \"Quantitative effect on ARR3 protein levels not measured\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Whether ARR3 mutations impair cone function directly—or myopia-associated elongation secondarily degrades cones—was resolved by ERG studies showing cone dysfunction (35% reduced a/b-wave, 55% reduced flicker) specific to ARR3 carriers versus myopes with intact ARR3, establishing a primary cone signaling deficit.\",\n      \"evidence\": \"Full-field electroretinography in genetically stratified ARR3-mutation carriers versus ARR3-intact high myopes\",\n      \"pmids\": [\"39420435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-center study; independent replication in larger cohorts needed\",\n        \"Which step in cone phototransduction is specifically disrupted remains unresolved\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"The cellular and molecular consequences of mosaic ARR3 loss were defined: ARR3 localizes to outer segments of M-cones from P14, and heterozygous loss in mice/rats shifts cone subtype proportions and alters Pde6h expression in M/S cones, suggesting that mosaicism disrupts phototransduction and generates defocus-like signals driving myopia.\",\n      \"evidence\": \"Developmental expression profiling, immunolocalization, retinal flatmounts in Arr3 knock-in mice and knockout rats, single-cell RNA sequencing\",\n      \"pmids\": [\"41493082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Causal link between cone mosaicism and axial elongation signaling not directly demonstrated\",\n        \"Downstream retinal signaling pathway translating phototransduction disruption into scleral growth not identified\",\n        \"Whether S-cone enrichment itself contributes to myopia signals is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which mosaic cone phototransduction disruption is transduced into scleral remodeling and axial elongation—the ultimate cause of myopia—remains unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No identification of retina-to-sclera signaling intermediates downstream of ARR3-dependent cone mosaicism\",\n        \"No structural model of ARR3 interaction with cone opsins\",\n        \"No therapeutic rescue experiments in animal models\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0098772\",\n        \"supporting_discovery_ids\": [4, 5]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005886\",\n        \"supporting_discovery_ids\": [5]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"GO:0009709\",\n        \"supporting_discovery_ids\": []\n      }\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PDE6H\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway — I should use Reactome IDs from the allowed list, not GO IDs. Let me also reconsider: the timeline doesn't strongly map to any of the allowed Reactome pathways. Signal Transduction is the closest fit. Let me also reconsider the localization — ARR3 localizes to outer segments of cone photoreceptors, which are modified cilia.\n\n```json\n{\n  \"mechanistic_narrative\": \"ARR3 encodes cone arrestin, a visual arrestin expressed in the outer segments of red/green cone photoreceptors that is required for normal cone phototransduction [PMID:41493082, PMID:39420435]. Loss-of-function mutations—including nonsense, splicing, and frameshift variants—cause premature termination and nonsense-mediated mRNA decay, abolishing ARR3 protein production [PMID:34966409, PMID:38517428]. Heterozygous loss-of-function variants in ARR3 cause X-linked female-limited early-onset high myopia (Myopia-26) through an X-chromosome inactivation mechanism that generates a mosaic retina in which ARR3-null and ARR3-expressing cones coexist, disrupting cone subtype composition, Pde6h expression, and phototransduction signaling [PMID:27829781, PMID:36769483, PMID:41493082]. ARR3 mutation carriers exhibit cone-specific electrophysiological dysfunction independent of axial elongation, confirming a primary role in cone photoreceptor signaling [PMID:39420435].\",\n  \"teleology\": [\n    {\n      \"year\": 2016,\n      \"claim\": \"The genetic basis of an unusual female-limited high myopia was unknown; linkage and exome sequencing in three families demonstrated that heterozygous loss-of-function ARR3 variants co-segregate with early-onset high myopia exclusively in females, establishing ARR3 as a disease gene with X-linked female-limited inheritance.\",\n      \"evidence\": \"Genome-wide linkage scan, whole exome sequencing, Sanger sequencing, and co-segregation analysis across three independent families\",\n      \"pmids\": [\"27829781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which ARR3 loss leads to myopia rather than retinal degeneration was unknown\",\n        \"Why hemizygous males are unaffected was unexplained\",\n        \"No functional assay of variant pathogenicity was performed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"It was unclear whether ARR3 truncating variants actually eliminate protein; demonstration that a nonsense ARR3 variant triggers nonsense-mediated mRNA decay established that complete loss of ARR3 protein is the pathogenic mechanism.\",\n      \"evidence\": \"Exome sequencing and functional NMD assay of c.569C>G (p.S190*) transcript\",\n      \"pmids\": [\"34966409\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"NMD demonstrated for a single variant; generalizability to other mutation classes not yet shown\",\n        \"No animal model to confirm loss-of-function consequences on cone physiology\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The paradox of female-limited disease from an X-linked gene was resolved when X-chromosome inactivation assays showed that heterozygous females have mosaic retinas with patches of mutant and wild-type ARR3-expressing cones, and skewed XCI correlated with phenotypic severity.\",\n      \"evidence\": \"X-chromosome inactivation analysis and phenotypic correlation in a family carrying a frameshift ARR3 variant\",\n      \"pmids\": [\"36769483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mosaic retinal pattern not directly visualized at cellular resolution in human tissue\",\n        \"Mechanism linking mosaicism to myopia signaling remained speculative\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanding the mutational spectrum, minigene assays demonstrated that ARR3 splicing variants introduce premature termination codons, confirming that disruption of mRNA processing is another pathogenic mechanism for early-onset high myopia.\",\n      \"evidence\": \"Minigene splicing assay for two novel ARR3 intronic variants (c.39+1G>A and c.100+4A>G)\",\n      \"pmids\": [\"38517428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Endogenous splicing consequences in cone photoreceptors not verified\",\n        \"Quantitative effect on ARR3 protein levels not measured\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Whether ARR3 mutations impair cone function directly or myopia-associated elongation secondarily degrades cones was resolved by ERG studies showing cone dysfunction specific to ARR3 carriers versus myopes with intact ARR3, establishing a primary cone signaling deficit.\",\n      \"evidence\": \"Full-field electroretinography in genetically stratified ARR3-mutation carriers versus ARR3-intact high myopes\",\n      \"pmids\": [\"39420435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-center study; independent replication in larger cohorts needed\",\n        \"Which step in cone phototransduction is specifically disrupted remains unresolved\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"The cellular and molecular consequences of mosaic ARR3 loss were defined: ARR3 localizes to outer segments of M-cones from P14, and heterozygous loss in mice and rats shifts cone subtype proportions and alters Pde6h expression in M/S cones, linking mosaicism to disrupted phototransduction signaling.\",\n      \"evidence\": \"Developmental expression profiling, immunolocalization, retinal flatmounts in Arr3 knock-in mice and knockout rats, single-cell RNA sequencing\",\n      \"pmids\": [\"41493082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Causal link between cone mosaicism and axial elongation signaling not directly demonstrated\",\n        \"Downstream retinal signaling pathway translating phototransduction disruption into scleral growth not identified\",\n        \"Whether S-cone enrichment itself contributes to myopia signals is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which mosaic cone phototransduction disruption is transduced into scleral remodeling and axial elongation—the ultimate cause of myopia—remains unknown.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No identification of retina-to-sclera signaling intermediates downstream of ARR3-dependent cone mosaicism\",\n        \"No structural model of ARR3 interaction with cone opsins\",\n        \"No therapeutic rescue experiments in animal models\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0098772\",\n        \"supporting_discovery_ids\": [4, 5]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005929\",\n        \"supporting_discovery_ids\": [5]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-162582\",\n        \"supporting_discovery_ids\": [4, 5]\n      },\n      {\n        \"term_id\": \"R-HSA-9709957\",\n        \"supporting_discovery_ids\": [4, 5]\n      }\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PDE6H\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}